FDAnews Drug Daily Bulletin

Pharma Blog Watch

July 7, 2006

New ARV Combination Treatment (DrugWonks.com)
In his entry, blogger Peter Pitts writes about the new 3-in-1 antiretroviral (ARV) HIV/AIDS treatment developed by Aurobindo Pharma, which was recently approved by the FDA.

Canadian DTC Advertising in the U.S. (Eye on FDA)
Why would direct-to-consumer (DTC) advertising solicit U.S. consumers to buy Canadian drugs? Blogger Mark Senak writes about cross-border ad campaigns in his entry.